| Artificial intelligence for COVID-19 drug discovery and vaccine development A Keshavarzi Arshadi, J Webb, M Salem, E Cruz, S Calad-Thomson, ... Frontiers in Artificial Intelligence 3, 65, 2020 | 209 | 2020 |
| DeepMalaria: Artificial Intelligence Driven Discovery of Potent Antiplasmodials A Keshavarzi Arshadi, M Salem, J Collins, JS Yuan, D Chakrabarti Frontiers in Pharmacology 10, 1526, 2020 | 54 | 2020 |
| AMPDeep: hemolytic activity prediction of antimicrobial peptides using transfer learning M Salem, A Keshavarzi Arshadi, JS Yuan BMC bioinformatics 23 (1), 389, 2022 | 17 | 2022 |
| MolData, a molecular benchmark for disease and target based machine learning A Keshavarzi Arshadi, M Salem, A Firouzbakht, JS Yuan Journal of cheminformatics 14 (1), 1-18, 2022 | 16 | 2022 |
| A systems medicine approach reveals disordered immune system and lipid metabolism in multiple sclerosis patients M Pazhouhandeh, MA Sahraian, SD Siadat, A Fateh, F Vaziri, F Tabrizi, ... Clinical & Experimental Immunology 192 (1), 18-32, 2018 | 15 | 2018 |
| Transcreen: transfer learning on graph-based anti-cancer virtual screening model M Salem, A Khormali, AK Arshadi, J Webb, JS Yuan Big Data and Cognitive Computing 4 (3), 16, 2020 | 10 | 2020 |
| Synthesis, structure–activity relationship, and antimalarial efficacy of 6-chloro-2-arylvinylquinolines G Huang, C Murillo Solano, J Melendez, J Shaw, J Collins, R Banks, ... Journal of medicinal chemistry 63 (20), 11756-11785, 2020 | 8 | 2020 |
| Cyclic Tetrapeptide HDAC Inhibitors with Improved Plasmodium falciparum Selectivity and Killing Profile JE Collins, JW Lee, MJ Bohmer, JD Welden, AK Arshadi, L Du, ... ACS infectious diseases 7 (10), 2889-2903, 2021 | 6 | 2021 |
| Artificial intelligence: Applications in healthcare delivery S Reddy CRC Press, 2020 | 5 | 2020 |
| Artificial Intelligence for COVID-19 drug discovery and vaccine development. Front Artif Intell 3: 65 A Keshavarzi Arshadi, J Webb, M Salem, E Cruz, S Calad-Thomson, ... | 5 | 2020 |
| & Yuan, JS (2020) A Keshavarzi Arshadi, J Webb, M Salem, E Cruz, S Calad-Thomson, ... Artificial intelligence for COVID-19 drug discovery and vaccine development …, 0 | 5 | |
| Keshavarzi Arshadi A K Arshadi Webb J., Salem M., Cruz E., Calad-Thomson S., Ghadirian N., Collins J., Diez …, 2020 | 4 | 2020 |
| Artificial intelligence-based methods for early drug discovery and related training methods JS Yuan, D Chakrabarti, M Salem, AK Arshadi US Patent App. 17/012,523, 2021 | 3 | 2021 |
| Functional microRNA-targeting drug discovery by graph-based deep learning AK Arshadi, M Salem, H Karner, K Garcia, A Arab, JS Yuan, H Goodarzi The Cell, Patterns, 100909, 2024 | 1 | 2024 |
| DEEP-LEARNING BASED METHODS FOR VIRTUAL SCREENING OF MOLECULES FOR MICRO RIBONUCLEIC ACID (MIRNA) DRUG DISCOVERY KESHAVARZI ARSHADI, Arash SALEM, Milad YUAN, Jiann-Shiun GOODARZI, Hani US Patent PCT/US2023/060,385, 2023 | | 2023 |
| Functional Based Drug Discovery With Artificial Intelligence A Keshavarzi Arshadi PhD Dissertation, 2022 | | 2022 |
| AI and Immunoinformatics A Keshavarzi Arshadi, M Salem Artificial Intelligence in Medicine, Springer Nature Book, 2021 | | 2021 |
| AI and Drug Discovery AK Arshadi, M Salem Book. Taylor & Francis Press, 55-65, 2020 | | 2020 |
| Application of deep learning in purchasing compound libraries for non-target based drug discovery JSY Milad Salem, Arash Keshavarzi Arshadi Conference of THE AMERICAN CHEMICAL SOCIETY, 2020 | | 2020 |
| Application of deep learning in purchasing compound libraries for non-target based drug discovery M Salem, AK Arshadi, JS Yuan American Chemical Society SciMeetings 1 (1), 2020 | | 2020 |
Milad SalemVilya TherapeuticsVerified email at vilyatx.com
